Moderna Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Moderna Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| operating activities | ||||||||||||||||||||||||||
| net income | -825,000,000 | -971,000,000 | -1,120,000,000 | 13,000,000 | -1,279,000,000 | -1,175,000,000 | 217,000,000 | -3,630,000,000 | -1,380,000,000 | 79,000,000 | 1,465,000,000 | 1,043,000,000 | 2,197,000,000 | 3,657,000,000 | 4,868,000,000 | 3,333,000,000 | 2,780,000,000 | 1,221,000,000 | -272,485,000 | -233,636,000 | -116,713,000 | -124,230,000 | -123,116,000 | -123,194,000 | -135,054,000 | -132,657,000 |
| adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||
| stock-based compensation | 130,000,000 | 115,000,000 | 104,000,000 | 112,000,000 | 112,000,000 | 101,000,000 | 79,000,000 | 77,000,000 | 74,000,000 | 75,000,000 | 62,000,000 | 70,000,000 | 50,000,000 | 44,000,000 | 37,000,000 | 40,000,000 | 35,000,000 | 30,000,000 | 25,479,000 | 23,206,000 | 23,923,000 | 20,413,000 | 20,326,000 | 20,804,000 | 21,495,000 | 18,497,000 |
| depreciation and amortization | 57,000,000 | 39,000,000 | 60,000,000 | 52,000,000 | 41,000,000 | 36,000,000 | 202,000,000 | 249,000,000 | 92,000,000 | 78,000,000 | 80,000,000 | 113,000,000 | 76,000,000 | 79,000,000 | 78,000,000 | 70,000,000 | 69,000,000 | 15,000,000 | 7,706,000 | 8,500,000 | 7,596,000 | 7,449,000 | 8,939,000 | 7,265,000 | 7,489,000 | 7,328,000 |
| amortization/accretion of investments | -18,000,000 | -19,000,000 | -19,000,000 | -21,000,000 | -28,000,000 | -27,000,000 | -20,000,000 | -12,000,000 | -12,000,000 | -17,000,000 | -4,000,000 | 6,000,000 | 11,000,000 | 18,000,000 | 21,000,000 | 20,000,000 | 8,000,000 | 5,000,000 | 5,132,000 | 3,106,000 | 1,432,000 | 515,000 | -314,000 | |||
| loss on equity investments | 0 | 8,000,000 | 9,000,000 | 13,000,000 | 19,000,000 | 18,000,000 | ||||||||||||||||||||
| other non-cash items | 34,000,000 | 2,000,000 | 54,000,000 | -1,000,000 | 4,000,000 | 3,000,000 | -18,000,000 | 37,000,000 | -8,000,000 | -4,000,000 | -8,000,000 | 21,000,000 | ||||||||||||||
| changes in assets and liabilities: | ||||||||||||||||||||||||||
| accounts receivable | 30,000,000 | 280,000,000 | 1,206,000,000 | -1,401,000,000 | -26,000,000 | 755,000,000 | 974,000,000 | -1,634,000,000 | 881,000,000 | 272,000,000 | 1,310,000,000 | -4,000,000 | 483,000,000 | 1,000,000 | -33,000,000 | -1,122,000,000 | 1,190,000,000 | -1,819,000,000 | -1,200,059,000 | -157,139,000 | -27,408,000 | -585,000 | -2,232,000 | 698,000 | 2,148,000 | 6,040,000 |
| prepaid expenses and other assets | -196,000,000 | 46,000,000 | 292,000,000 | -150,000,000 | 0 | 3,000,000 | 202,000,000 | 914,000,000 | 70,000,000 | -212,000,000 | -1,030,000,000 | -345,000,000 | 90,000,000 | -414,000,000 | -303,000,000 | -76,000,000 | -98,000,000 | -12,000,000 | -173,047,000 | -56,206,000 | -7,483,000 | -4,305,000 | 11,158,000 | -3,722,000 | -998,000 | 3,313,000 |
| inventory | -114,000,000 | -8,000,000 | 291,000,000 | -11,000,000 | -104,000,000 | -93,000,000 | 285,000,000 | 228,000,000 | 18,000,000 | 216,000,000 | 1,128,000,000 | -156,000,000 | 21,000,000 | -501,000,000 | -476,000,000 | -322,000,000 | -148,000,000 | -448,000,000 | ||||||||
| right-of-use assets, operating leases | 10,000,000 | 9,000,000 | 10,000,000 | -1,000,000 | -78,000,000 | 16,000,000 | 52,000,000 | -648,000,000 | -13,000,000 | 4,000,000 | -8,000,000 | 9,000,000 | 10,000,000 | 10,000,000 | -33,000,000 | -11,000,000 | -16,000,000 | 2,000,000 | 2,575,000 | -730,000 | 1,732,000 | -14,119,000 | ||||
| accounts payable | -47,000,000 | -156,000,000 | 34,000,000 | 96,000,000 | 104,000,000 | -303,000,000 | 21,000,000 | 179,000,000 | -70,000,000 | -117,000,000 | 151,000,000 | 145,000,000 | -21,000,000 | -35,000,000 | 178,000,000 | -18,000,000 | 59,000,000 | -15,000,000 | -1,758,000 | 2,160,000 | 9,142,000 | 2,331,000 | -4,779,000 | -17,714,000 | -3,202,000 | 1,731,000 |
| accrued liabilities | -14,000,000 | -381,000,000 | 30,000,000 | 49,000,000 | -66,000,000 | -398,000,000 | -403,000,000 | 696,000,000 | -138,000,000 | -495,000,000 | 258,000,000 | 49,000,000 | 191,000,000 | 114,000,000 | 389,000,000 | 233,000,000 | 82,000,000 | 285,000,000 | 256,018,000 | 112,185,000 | 33,142,000 | -12,953,000 | 4,891,000 | 19,543,000 | 4,761,000 | -32,557,000 |
| deferred revenue | 97,000,000 | -29,000,000 | -262,000,000 | -323,000,000 | 179,000,000 | -33,000,000 | -887,000,000 | -194,000,000 | -160,000,000 | -819,000,000 | -1,466,000,000 | -321,000,000 | -1,565,000,000 | -805,000,000 | -1,607,000,000 | 998,000,000 | -233,000,000 | 3,666,000,000 | 2,602,338,000 | 1,188,552,000 | 51,891,000 | -474,000 | -11,324,000 | -9,695,000 | -7,496,000 | -15,604,000 |
| operating lease liabilities | -5,000,000 | -5,000,000 | -5,000,000 | 8,000,000 | 31,000,000 | -6,000,000 | -54,000,000 | 593,000,000 | 8,000,000 | 4,000,000 | 13,000,000 | -8,000,000 | -9,000,000 | -10,000,000 | 9,000,000 | 0 | 10,000,000 | -2,000,000 | -2,625,000 | 410,000 | -1,237,000 | 15,244,000 | ||||
| other liabilities | -58,000,000 | 33,000,000 | 83,000,000 | 6,000,000 | -141,000,000 | 130,000,000 | 52,000,000 | 39,000,000 | -3,000,000 | -15,000,000 | -185,000,000 | 10,000,000 | 228,000,000 | 35,000,000 | 100,000,000 | -417,000,000 | 347,000,000 | 93,000,000 | -695,000 | 2,279,000 | -1,327,000 | 5,732,000 | -7,786,000 | 1,564,000 | -431,000 | 484,000 |
| net cash from operating activities | -919,000,000 | -1,037,000,000 | 825,000,000 | -1,566,000,000 | -1,274,000,000 | -989,000,000 | 622,000,000 | -1,600,000,000 | -915,000,000 | -1,225,000,000 | 1,662,000,000 | 252,000,000 | 304,000,000 | 2,763,000,000 | 3,310,000,000 | 3,276,000,000 | 4,063,000,000 | 2,971,000,000 | 1,264,289,000 | 892,748,000 | -23,875,000 | -106,191,000 | -95,773,000 | -107,048,000 | -112,220,000 | -143,927,000 |
| capex | -6,000,000 | -67,000,000 | -522,000,000 | -159,000,000 | -187,000,000 | -105,000,000 | -220,000,000 | -97,000,000 | -227,000,000 | -15,000,000 | 0 | -58,000,000 | -102,000,000 | -68,000,000 | -75,000,000 | -78,000,000 | -6,000,000 | -14,000,000 | -18,964,000 | -15,222,000 | -16,032,000 | 387,000 | -3,849,000 | -10,922,000 | -18,639,000 | 6,532,000 |
| free cash flows | -925,000,000 | -1,104,000,000 | 303,000,000 | -1,725,000,000 | -1,461,000,000 | -1,094,000,000 | 402,000,000 | -1,697,000,000 | -1,142,000,000 | -1,240,000,000 | 1,662,000,000 | 194,000,000 | 202,000,000 | 2,695,000,000 | 3,235,000,000 | 3,198,000,000 | 4,057,000,000 | 2,957,000,000 | 1,245,325,000 | 877,526,000 | -39,907,000 | -105,804,000 | -99,622,000 | -117,970,000 | -130,859,000 | -137,395,000 |
| investing activities | ||||||||||||||||||||||||||
| purchases of marketable securities | -1,295,000,000 | -1,764,000,000 | -1,888,000,000 | -1,251,000,000 | -846,000,000 | -2,544,000,000 | -1,663,000,000 | -816,000,000 | -196,000,000 | -1,085,000,000 | -2,510,000,000 | -191,000,000 | -3,162,000,000 | -5,572,000,000 | -2,373,000,000 | -3,720,000,000 | -5,833,000,000 | -726,000,000 | -630,154,000 | -1,422,528,000 | -282,356,000 | -621,257,000 | -195,949,000 | -105,964,000 | -413,796,000 | -429,517,000 |
| proceeds from maturities of marketable securities | 1,491,000,000 | 1,933,000,000 | 914,000,000 | 1,112,000,000 | 1,963,000,000 | 1,573,000,000 | 864,000,000 | 1,447,000,000 | 1,904,000,000 | 1,360,000,000 | 929,000,000 | 813,000,000 | 968,000,000 | 441,000,000 | 263,000,000 | 215,000,000 | 521,000,000 | 339,000,000 | 388,977,000 | 231,239,000 | 247,180,000 | 269,733,000 | 245,335,000 | 184,212,000 | 159,694,000 | 403,940,000 |
| proceeds from sales of marketable securities | 371,000,000 | 688,000,000 | 957,000,000 | 1,011,000,000 | 714,000,000 | 1,285,000,000 | 481,000,000 | 298,000,000 | 470,000,000 | 1,957,000,000 | 630,000,000 | 412,000,000 | 1,129,000,000 | 1,377,000,000 | 1,122,000,000 | 277,000,000 | 1,464,000,000 | 242,000,000 | 74,349,000 | 32,321,000 | 66,287,000 | 41,729,000 | 87,624,000 | 41,830,000 | 17,787,000 | 21,413,000 |
| purchases of property, plant and equipment | -3,000,000 | -117,000,000 | -522,000,000 | -151,000,000 | -182,000,000 | -196,000,000 | -220,000,000 | -140,000,000 | -234,000,000 | -113,000,000 | ||||||||||||||||
| purchase of intangible asset | 0 | -10,000,000 | ||||||||||||||||||||||||
| net cash from investing activities | 564,000,000 | 730,000,000 | -539,000,000 | 721,000,000 | 1,649,000,000 | 118,000,000 | -538,000,000 | 789,000,000 | 1,944,000,000 | 2,011,000,000 | -1,048,000,000 | 945,000,000 | -1,152,000,000 | -3,921,000,000 | -1,138,000,000 | -3,327,000,000 | -3,878,000,000 | -180,000,000 | -190,129,000 | -1,178,260,000 | 12,479,000 | -316,018,000 | 130,348,000 | 113,367,000 | -246,901,000 | -11,759,000 |
| financing activities | ||||||||||||||||||||||||||
| proceeds from issuance of common stock through equity plans | 14,000,000 | 3,000,000 | 11,000,000 | 8,000,000 | 32,000,000 | 15,000,000 | 15,000,000 | 6,000,000 | 16,000,000 | 9,000,000 | 25,000,000 | 11,000,000 | 17,000,000 | 12,000,000 | 28,000,000 | 32,000,000 | 36,000,000 | 28,000,000 | 26,815,000 | 78,197,000 | 28,357,000 | 15,554,000 | 3,930,000 | 57,000 | ||
| tax payments related to net share settlements on equity awards | 0 | -1,000,000 | ||||||||||||||||||||||||
| changes in financing lease liabilities | -5,000,000 | 2,000,000 | -14,000,000 | 3,000,000 | 2,000,000 | -1,000,000 | -124,000,000 | -65,000,000 | -56,000,000 | -25,000,000 | -61,000,000 | -46,000,000 | -46,000,000 | -31,000,000 | -44,000,000 | -34,000,000 | -60,000,000 | -2,000,000 | ||||||||
| net cash from financing activities | 9,000,000 | 4,000,000 | -3,000,000 | 11,000,000 | 34,000,000 | 14,000,000 | -109,000,000 | -58,000,000 | -668,000,000 | -542,000,000 | -438,000,000 | -1,041,000,000 | -1,327,000,000 | -642,000,000 | -24,000,000 | 26,000,000 | 44,109,000 | 29,726,000 | 1,381,305,000 | 578,053,000 | 27,590,000 | 15,767,000 | 7,812,000 | -48,000 | ||
| effect of changes in exchange rates on cash and cash equivalents | ||||||||||||||||||||||||||
| net decrease in cash, cash equivalents and restricted cash | -345,000,000 | -303,000,000 | 282,000,000 | -155,734,000 | ||||||||||||||||||||||
| cash, cash equivalents and restricted cash, beginning of year | 0 | 1,929,000,000 | 0 | 0 | 0 | 2,928,000,000 | 0 | 0 | 0 | 3,217,000,000 | 0 | 0 | 0 | 6,860,000,000 | 0 | 0 | 0 | 2,636,000,000 | 0 | 0 | 0 | 247,699,000 | 0 | 0 | 0 | 670,491,000 |
| cash, cash equivalents and restricted cash, end of period | -345,000,000 | 1,626,000,000 | -833,000,000 | 409,000,000 | 2,071,000,000 | -869,000,000 | 361,000,000 | 3,461,000,000 | 156,000,000 | -2,175,000,000 | 5,060,000,000 | -53,000,000 | 161,000,000 | 5,453,000,000 | -255,786,000 | 1,369,909,000 | 403,543,000 | 22,086,000 | -351,309,000 | 514,757,000 | ||||||
| non-cash investing and financing activities | ||||||||||||||||||||||||||
| purchases of property and equipment included in accounts payable and accrued liabilities | -3,000,000 | 50,000,000 | -8,000,000 | -5,000,000 | 91,000,000 | 43,000,000 | 7,000,000 | 98,000,000 | 31,000,000 | -15,000,000 | 64,000,000 | 45,000,000 | 21,000,000 | 24,000,000 | 21,000,000 | 4,337,000 | 4,070,000 | 2,600,000 | 6,610,000 | 2,813,000 | -4,211,000 | -8,053,000 | 14,127,000 | |||
| changes in assets and liabilities, net of acquisition of business: | ||||||||||||||||||||||||||
| acquisition of business, net of cash acquired | 0 | 0 | 0 | -85,000,000 | ||||||||||||||||||||||
| investment in convertible notes and equity securities | 0 | 0 | 0 | -23,000,000 | ||||||||||||||||||||||
| repurchase of common stock, including excise tax | 0 | |||||||||||||||||||||||||
| cash, cash equivalents and restricted cash, end of year | ||||||||||||||||||||||||||
| supplemental cash flow information | ||||||||||||||||||||||||||
| cash paid (received) for income taxes | ||||||||||||||||||||||||||
| cash paid for interest | ||||||||||||||||||||||||||
| purchases of property, plant and equipment included in accounts payable and accrued liabilities | ||||||||||||||||||||||||||
| deferred income taxes | -106,000,000 | 1,464,000,000 | -220,000,000 | -310,000,000 | -86,000,000 | -97,000,000 | -230,000,000 | -146,000,000 | -229,000,000 | -17,000,000 | -22,000,000 | -50,000,000 | ||||||||||||||
| income taxes payable | -2,000,000 | -45,000,000 | -11,000,000 | 7,000,000 | 9,000,000 | -19,000,000 | 18,000,000 | -18,000,000 | -283,000,000 | -1,243,000,000 | 716,000,000 | 311,000,000 | ||||||||||||||
| right-of-use assets obtained through finance lease modifications and reassessments | 163,000,000 | 1,000,000 | 312,000,000 | 51,000,000 | ||||||||||||||||||||||
| right-of-use assets obtained in exchange for financing lease liabilities | 687,000,000 | 0 | 94,000,000 | 0 | ||||||||||||||||||||||
| gain on equity investments | ||||||||||||||||||||||||||
| net increase in cash, cash equivalents and restricted cash | 409,000,000 | -857,000,000 | 361,000,000 | 244,000,000 | 176,000,000 | 156,000,000 | -2,175,000,000 | -1,800,000,000 | 1,299,000,000 | -53,000,000 | 161,000,000 | 2,817,000,000 | 1,118,269,000 | -255,786,000 | 1,369,909,000 | 155,844,000 | 62,165,000 | 22,086,000 | ||||||||
| cash (received) paid for income taxes | ||||||||||||||||||||||||||
| repurchase of common stock | -628,000,000 | -526,000,000 | -1,006,000,000 | -1,298,000,000 | -623,000,000 | |||||||||||||||||||||
| right-of-use assets reduced through finance lease modifications and reassessments | -60,000,000 | |||||||||||||||||||||||||
| leased assets expensed | ||||||||||||||||||||||||||
| proceeds from offerings of common stock, net of issuance costs | ||||||||||||||||||||||||||
| repurchases of common stock | ||||||||||||||||||||||||||
| cash paid for income taxes | ||||||||||||||||||||||||||
| purchases of property and equipment | -89,000,000 | -87,000,000 | -132,000,000 | -120,000,000 | -99,000,000 | -30,000,000 | -35,000,000 | -23,301,000 | -19,292,000 | -18,632,000 | -6,223,000 | -6,662,000 | -6,711,000 | -10,586,000 | -7,595,000 | |||||||||||
| investment in convertible notes | 0 | 0 | -35,000,000 | |||||||||||||||||||||||
| proceeds from public offerings of common stock, net of issuance costs | ||||||||||||||||||||||||||
| loss on disposal of property and equipment | -49,000 | 61,000 | 89,000 | 137,000 | 246,000 | 56,000 | -5,000 | 19,000 | ||||||||||||||||||
| deferred lease obligation | 2,811,000 | 483,000 | 550,000 | |||||||||||||||||||||||
| proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | ||||||||||||||||||||||||||
| repurchases of redeemable convertible preferred stock | ||||||||||||||||||||||||||
| proceeds from issuance of common stock under equity plans | ||||||||||||||||||||||||||
| proceeds from purchase of common stock under employee stock purchase plan | 4,123,000 | |||||||||||||||||||||||||
| charges to financing lease liabilities | -6,254,000 | |||||||||||||||||||||||||
| reimbursement of assets under financing lease obligation | ||||||||||||||||||||||||||
| payments on financing lease obligation | 213,000 | 204,000 | -105,000 | |||||||||||||||||||||||
| issuance costs included in accounts payable and accrued liabilities | 796,000 | |||||||||||||||||||||||||
| leasehold improvements included in prepaid and other current assets | 0 | -3,779,000 | 10,089,000 | |||||||||||||||||||||||
| lease financing obligation | 10,089,000 | |||||||||||||||||||||||||
| proceeds from public offering of common stock, net of issuance costs | 1,303,304,000 | 549,455,000 | ||||||||||||||||||||||||
| charges to financing lease obligation | -196,000 | 241,000 | ||||||||||||||||||||||||
| accounts receivable from related party | -1,346,000 | 5,079,000 | -4,396,000 | -55,000 | -66,000 | |||||||||||||||||||||
| proceeds from initial public offering of common stock, net of issuance costs | ||||||||||||||||||||||||||
| distributions to preferred and common unit holders | ||||||||||||||||||||||||||
| income taxes paid | ||||||||||||||||||||||||||
| interest in connection with financing lease obligation | ||||||||||||||||||||||||||
| reimbursement of assets under lease financing obligation | 0 | |||||||||||||||||||||||||
| amortization of investment premiums | -1,355,000 | -1,005,000 | ||||||||||||||||||||||||
| adjustments to reconcile net income to net cash (used in) operating activities: | ||||||||||||||||||||||||||
| amortization of investment premiums and discounts | ||||||||||||||||||||||||||
| accounts receivable from affiliate | ||||||||||||||||||||||||||
| decrease (increase) in restricted cash | ||||||||||||||||||||||||||
| net increase in cash and cash equivalents | ||||||||||||||||||||||||||
| cash and cash equivalents, beginning of year | ||||||||||||||||||||||||||
| cash and cash equivalents, end of year | ||||||||||||||||||||||||||
| dividends and accretion of redeemable convertible preferred units | ||||||||||||||||||||||||||
| tax distributions to members included in accounts payable and accrued liabilities |
We provide you with 20 years of cash flow statements for Moderna stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Moderna stock. Explore the full financial landscape of Moderna stock with our expertly curated income statements.
The information provided in this report about Moderna stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.